Xencor Balance Sheet
NASDAQ: XNCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Xencor financial position
At the end of fiscal 2025, Xencor reported total assets of $875.5 million, down 8.0% from a year earlier against total liabilities of $239.9 million. Shareholders' equity stood at $635.6 million, or 72.6% of assets. The company held $54.1 million in cash and equivalents against $119.7 million of debt, a net debt position of $65.7 million.
The current ratio (current assets divided by current liabilities) was 6.25, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.19.
Summary generated from market data by MetaCap's automated system. Methodology
Xencor balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 54.07M | 40.88M | 53.79M | 53.94M | 143.48M | 163.54M | 50.31M | 26.25M | 16.53M | 14.53M |
| Short-Term Investments | — | — | — | — | — | — | 479.47M | 268.12M | 207.60M | 115.61M |
| Receivables | 29.30M | 60.85M | 23.74M | 29.00M | 66.38M | 11.44M | 21.57M | 10.19M | 1.14M | 8.62M |
| Total Current Assets | 599.82M | 577.60M | 635.60M | 675.34M | 424.37M | 637.67M | 558.40M | 315.73M | 230.88M | 141.65M |
| Property, Plant & Equipment | 53.31M | 59.80M | 66.12M | 59.18M | 28.24M | 21.68M | 15.80M | 11.81M | 7.09M | 3.10M |
| Intangible Assets | 8.38M | 18.48M | 18.66M | 18.50M | 16.49M | 15.98M | 14.42M | 11.97M | 11.15M | 10.36M |
| Long-Term Investments | — | — | — | — | — | — | 71.53M | 236.11M | 139.20M | 273.34M |
| Total Assets | 875.50M | 951.95M | 965.13M | 846.27M | 838.21M | 703.24M | 670.25M | 576.73M | 390.20M | 428.56M |
| Accounts Payable | 10.83M | 16.76M | 13.91M | 10.09M | 14.00M | 8.95M | 10.19M | 3.80M | 6.87M | 3.88M |
| Short-Term Debt | 43.27M | 48.45M | 27.71M | 0 | — | — | — | — | — | — |
| Total Current Liabilities | 95.91M | 87.43M | 73.92M | 63.84M | 70.74M | 121.06M | 66.56M | 53.85M | 72.65M | 106.29M |
| Long-Term Debt | 76.48M | 115.16M | 161.77M | 0 | — | — | — | — | — | — |
| Total Liabilities | 239.91M | 277.92M | 303.05M | 118.77M | 104.71M | 130.80M | 77.05M | 55.05M | 73.74M | 114.61M |
| Shareholders' Equity | 635.59M | 677.61M | 661.75M | 727.50M | 733.50M | 572.44M | 593.20M | 521.68M | 316.46M | 337.93M |
| Retained Earnings | -795.96M | -704.04M | -471.42M | -338.29M | -283.10M | -365.74M | -296.40M | -323.28M | -252.87M | -237.96M |
| Total Debt | 119.75M | 163.61M | 189.48M | 0 | — | — | — | — | — | — |
| Net Cash (Debt) | -65.68M | -122.73M | -135.69M | 53.94M | 143.48M | 163.54M | 529.78M | 294.36M | 224.13M | 130.14M |
| Shares Outstanding | 71.87M | 70.26M | 61.00M | 60.00M | 59.36M | 57.87M | 56.90M | 56.28M | 47.00M | 46.57M |
This table shows 10 annual periods of Xencor's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow XNCR's reporting calendar. What is a balance sheet?